Difference between revisions of "Part:BBa K2623032"
(→Summary) |
|||
Line 3: | Line 3: | ||
<partinfo>BBa_K2623032 short</partinfo> | <partinfo>BBa_K2623032 short</partinfo> | ||
===Summary=== | ===Summary=== | ||
− | Our OMVs module is designed for siRNA delivery and then for cancer treatment. To demonstrate the conjugation of the L7Ae-C/ | + | Our OMVs module is designed for siRNA delivery and then for cancer treatment. To demonstrate the conjugation of the L7Ae-C/D<sub>box</sub> inside OMVs, we linked ST/SC part with the box part (<partinfo>BBa_K2623027</partinfo>) to form our total circuit (BBa_K2623032).The box part can code siRNA target for Kras in human pancreatic ductal adenocarcinoma (PDAC) with a C/Dbox RNA structure to bind with L7Ae. |
+ | |||
===Usage and Biology=== | ===Usage and Biology=== | ||
Under the induction of IPTG and Arabinose, this part can code SpyTag-OmpA, SpyCatcher-L7Ae and siRNA-C/Dbox to be encapsulated into OMVs through the isopeptide bond formed between SpyTag/SpyCatcher and the linkage between L7Ae and C/Dbox (Figure 1). | Under the induction of IPTG and Arabinose, this part can code SpyTag-OmpA, SpyCatcher-L7Ae and siRNA-C/Dbox to be encapsulated into OMVs through the isopeptide bond formed between SpyTag/SpyCatcher and the linkage between L7Ae and C/Dbox (Figure 1). |
Revision as of 18:06, 17 October 2018
A composite part linked by BBa_K2623024, BBa_K2623026 and BBa_K2623027
Summary
Our OMVs module is designed for siRNA delivery and then for cancer treatment. To demonstrate the conjugation of the L7Ae-C/Dbox inside OMVs, we linked ST/SC part with the box part (BBa_K2623027) to form our total circuit (BBa_K2623032).The box part can code siRNA target for Kras in human pancreatic ductal adenocarcinoma (PDAC) with a C/Dbox RNA structure to bind with L7Ae.
Usage and Biology
Under the induction of IPTG and Arabinose, this part can code SpyTag-OmpA, SpyCatcher-L7Ae and siRNA-C/Dbox to be encapsulated into OMVs through the isopeptide bond formed between SpyTag/SpyCatcher and the linkage between L7Ae and C/Dbox (Figure 1).
Characterization
We isolated OMVs according to our protocols and then stained the OMVs isolates with SYTOTMRNASelectTM at 10 μM . The stained isolates were analyzed by HSFCM (Figure 2).
Figure 2 are bivariate dot-plots of green fluorescence versus side scattering (SSC) for our OMVs isolates. E. coli BL21 transfected with BBa_K2623029 and BBa_K2623032 respectively were cultured in 100 mL OMVs-free LB culture for about 5 hours to get a OD600 at 0.6-0.8, in which BBa_K2623029 was set as negative control. Then Arabinose was added to a final concentration at 0.2% and after incubation for another 2 hours, IPTG was added to a final concentration at 0.5 mM and then nurtured the bacteria overnight. OMVs were isolated according to our protocols and stained with SYTOTM RNASelectTM. The stain OMVs were analyzed by HSFCM. As we expected, OMVs isolated from BBa_K2623032 could secret more OMVs containing with RNA stained positively by SYTOTM RNASelectTM than BBa_K2623029, indicating that our L7Ae and C/Dbox could fulfill their function. It’s a pity that we didn’t have cell culture experiment to test our siOMVs to silence Kras in human pancreatic ductal adenocarcinoma (PDAC). In our future plans, we’ll finish our cell experiment and demonstrate the function of our siOMVs.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 7
Illegal NheI site found at 30
Illegal NheI site found at 1965
Illegal NheI site found at 1988 - 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 3974
Illegal BamHI site found at 3850
Illegal BamHI site found at 4004 - 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 65
Illegal AgeI site found at 3685
Illegal AgeI site found at 4010 - 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI site found at 3667